Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

  title={Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia},
  author={Abraham Borer and Lisa Saidel-Odes and Klaris Riesenberg and Seada Eskira and Nejama Peled and Ronit Nativ and F. Schlaeffer and Michael Sherf},
  journal={Infection Control \&\#x0026; Hospital Epidemiology},
  pages={972 - 976}
Objective. To determine the attributable (direct) mortality and morbidity caused by carbapenem-resistant Klebsiella pneumoniae bacteremia. Design. A matched retrospective, historical cohort design, using a stepwise procedure to stringendy match the best control subjects to the best case subjects. Setting. A 1,000-bed tertiary-care university teaching hospital. Patients. Case subjects were defined as adult patients with carbapenem-resistant K. pneumoniae bacteremia during the period from October… 

A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.

Exposure to carbapenems is an independent risk factor for CRKP infection among intensive care unit (ICU) patients and patients with this clinical factor should be targeted for interventions to reduce the subsequent risk of infection.

The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents

An improved understanding of carbapenem-resistant Klebsiella pneumoniae (CRKP) in long-term acute care hospitals (LTACHs) is needed, including targeted surveillance screening of high-risk patients and effective antibiotic stewardship measures.

Infection related to Klebsiella pneumoniae producing carbapenemase in renal transplant patients.

The risk of acquisition of this bacterium was directly related to invasive procedures and exposure to the hospital environment and the findings reinforce the importance of prevention measures and control of infection by this microorganism.

Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Serious Threat in ICUs

  • A. UluB. Kurtaran Y. Taşova
  • Medicine, Biology
    Medical science monitor : international medical journal of experimental and clinical research
  • 2015
Restriction of third-generation cephalosporin and carbapenem use and invasive procedures, along with infection control precautions and disinfection policies, may be effective in reducing the carbAPenem resistance in ICUs.

Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.

Population-Based Incidence of Carbapenem-Resistant Klebsiella pneumoniae along the Continuum of Care, Los Angeles County

CRKP is more present in LAC than suspected and rates were consistently higher in LTACs than in ACHs, and Heightened awareness of this problem is needed in all LAC healthcare facilities, as patients access services along the continuum of care.

Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.




Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.

The data suggest that prior exposure to fluoroquinolones and antipseudomonal penicillins are independent risk factors for the development of CRKp infections.

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality.

The historical cohort study concludes that VRE bacteremia is associated with high rates of severe sepsis and septic shock, and patients who have V RE bacterenmia are twice as likely to die than closely matched controls.

Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality

CRKP affects patients with poor functional status, an ICU stay, and antibiotic exposure and is an independent predictor of death.

Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay.

Coagulase-negative staphylococci, the leading organisms causing hospital-acquired bacteremias, are associated with mortality in excess of that due to the underlying diseases alone, and they significantly prolong the length of hospital stay.

Attributable mortality of nosocomial candidemia, revisited.

Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis

Most studies have had inadequate sample size, inadequate adjustment for other predictors of adverse outcomes, or both, but available data suggest that VREB is associated with higher recurrence, mortality, and excess costs than VSEB including multiple studies adjusting for severity of illness.

Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.

The attributable mortality from nosocomial bloodstream infection is high in critically ill patients and is associated with a doubling of the SICU stay, an excess length of hospital stay of 24 days in survivors, and a significant economic burden.

Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis

The use of intravenous colistin for the treatment of infections due to multidrug-resistant gram-negative bacteria appears to be safe and effective, and the absence of a control group constitutes the major limitations of this study.

Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.

Attributable mortality of Stenotrophomonas maltophilia bacteremia.

The attributable mortality rate for S. maltophilia bacteremia is similar to the attributable mortality Rate for other nosocomial bloodstream infections and the mortality risk ratio is an 8-fold increase.